Jennifer M. Kim

Array ( [id] => 10627574 [patent_doc_number] => 09345714 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Method of treating middle ear infections' [patent_app_type] => utility [patent_app_number] => 14/838637 [patent_app_country] => US [patent_app_date] => 2015-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6960 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14838637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12191644 [patent_doc_number] => 09895356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-20 [patent_title] => 'Methods and compositions for treating anxiety' [patent_app_type] => utility [patent_app_number] => 14/837717 [patent_app_country] => US [patent_app_date] => 2015-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12766 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14837717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10735808 [patent_doc_number] => 20160081958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'USE OF METHIONINE SULFOXIMINE TO TREAT DISEASES CAUSED BY AN INFLAMMATORY CYTOKINE RESPONSE' [patent_app_type] => utility [patent_app_number] => 14/833543 [patent_app_country] => US [patent_app_date] => 2015-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10888 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14833543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11249249 [patent_doc_number] => 09474734 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-25 [patent_title] => 'Compounds for treating inflammation and pain' [patent_app_type] => utility [patent_app_number] => 14/832681 [patent_app_country] => US [patent_app_date] => 2015-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8530 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14832681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11330916 [patent_doc_number] => 09522148 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-20 [patent_title] => 'Use of levocetirizine and montelukast in the treatment of traumatic injury' [patent_app_type] => utility [patent_app_number] => 14/831469 [patent_app_country] => US [patent_app_date] => 2015-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15293 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14831469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10457860 [patent_doc_number] => 20150342876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-03 [patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OCULAR INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 14/823168 [patent_app_country] => US [patent_app_date] => 2015-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6100 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14823168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10996259 [patent_doc_number] => 20160193204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 14/817581 [patent_app_country] => US [patent_app_date] => 2015-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 25393 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14817581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10450745 [patent_doc_number] => 20150335759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-26 [patent_title] => 'Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use Thereof' [patent_app_type] => utility [patent_app_number] => 14/816915 [patent_app_country] => US [patent_app_date] => 2015-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 20542 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14816915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10685716 [patent_doc_number] => 20160031861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'SUBSTITUTED OXETANES AND THEIR USE AS INHIBITORS OF CATHEPSIN C' [patent_app_type] => utility [patent_app_number] => 14/814759 [patent_app_country] => US [patent_app_date] => 2015-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14183 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14814759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11805139 [patent_doc_number] => 09546151 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-17 [patent_title] => 'VMAT inhibitory compounds' [patent_app_type] => utility [patent_app_number] => 14/815356 [patent_app_country] => US [patent_app_date] => 2015-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42091 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14815356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10662170 [patent_doc_number] => 20160008314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'METHOD FOR TREATING CONTACT DERMATITIS' [patent_app_type] => utility [patent_app_number] => 14/796809 [patent_app_country] => US [patent_app_date] => 2015-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6010 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14796809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10511042 [patent_doc_number] => 09238616 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-19 [patent_title] => 'Prodrugs of gaba analogs, compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/792243 [patent_app_country] => US [patent_app_date] => 2015-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41119 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14792243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11330911 [patent_doc_number] => 09522140 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-20 [patent_title] => 'Aryl substituted carboxamide derivatives as calcium or sodium channel blockers' [patent_app_type] => utility [patent_app_number] => 14/790596 [patent_app_country] => US [patent_app_date] => 2015-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65106 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14790596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10774689 [patent_doc_number] => 20160120845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'Methods of Treating Psoriasis Using Allantoin' [patent_app_type] => utility [patent_app_number] => 14/789173 [patent_app_country] => US [patent_app_date] => 2015-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19186 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14789173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10670805 [patent_doc_number] => 20160016948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF T790M CONTAINING EGFR MUTANTS' [patent_app_type] => utility [patent_app_number] => 14/745159 [patent_app_country] => US [patent_app_date] => 2015-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 203783 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14745159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10474772 [patent_doc_number] => 20150359789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-17 [patent_title] => 'METHODS FOR TREATING PRURITUS' [patent_app_type] => utility [patent_app_number] => 14/738550 [patent_app_country] => US [patent_app_date] => 2015-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 40177 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14738550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10468575 [patent_doc_number] => 20150353591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'TITANOCENE-GOLD DERIVATIVES COMPRISING THIOLATO LIGANDS' [patent_app_type] => utility [patent_app_number] => 14/731842 [patent_app_country] => US [patent_app_date] => 2015-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7089 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14731842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14143031 [patent_doc_number] => 10251867 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-09 [patent_title] => Dosing regimen for a selective S1P [patent_app_type] => utility [patent_app_number] => 14/732013 [patent_app_country] => US [patent_app_date] => 2015-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3694 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14732013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10373015 [patent_doc_number] => 20150258021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-17 [patent_title] => 'INHALANT PROPELLANT-FREE AEROSOL FORMULATION' [patent_app_type] => utility [patent_app_number] => 14/726923 [patent_app_country] => US [patent_app_date] => 2015-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8795 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14726923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10459387 [patent_doc_number] => 20150344402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-03 [patent_title] => 'Omefibrates for Treating Dyslipidemia and Cardiovascular Disease' [patent_app_type] => utility [patent_app_number] => 14/721258 [patent_app_country] => US [patent_app_date] => 2015-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9019 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14721258 [rel_patent_id] =>[rel_patent_doc_number] =>)